Medications

Questions over value of new antibiotics to tackle resistance

In the first installment of a new series, Peter Doshi, Assistant Professor at the University of Maryland School of Pharmacy and Associate Editor at The BMJ, asks why authorities are approving drugs with little evidence they ...

Medications

Most information in drug development is lost

Lots of potentially useful medical information is getting lost. McGill researchers discovered this when they looked into the lack of reporting of information from "stalled drug" trials in cancer, cardiovascular and neurological ...

Medications

FDA drug approvals reached 18-year high in 2014

The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years.

Medications

Study examines FDA influence on design of pivotal drug studies

An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future studies finds that one-quarter of recent new drug approvals occurred without any ...

Other

ReWalk receives FDA approval, clearing the way for US sales

There is good news for those suffering from spinal cord injuries. The U.S. Food and Drug Administration gave its stamp of approval to ReWalk—the exoskeleton that enables paraplegics to walk. While the device has sparked ...

page 15 from 24